Hyliion raises 2026 revenue guidance to about $15M following $41.7M U.S. Navy contract

OptimizeRx reiterates $95M-$100M 2026 revenue outlook amid CFO transition

Biostem raises 2026 revenue outlook to $26M-$29M while targeting manufacturing transfer in H1 2027

Intellinetics expects double-digit SaaS growth for fiscal 2026 while outlining a 2-4 year shift toward recurring revenue

Nortech outlines backlog strength with $93.8M total orders, as Q2 net sales rise 9.3% to $33.5M